Clinical studies on the effectiveness of Wratizolin in the treatment of some dermatoses.
Clinical studies on therapeutic effectiveness of ITCL applied as 2-3% ointment, 2% cream and 2-3% lotion were carried out. The study material included 96 patients at the age of 9-80. Of this group, 19 patients were with herpes zoster, 16 with herpes simplex, 29 with eczema complicated by secondary bacterial infection, 30 with palm and foot pustulosis, 1 patient with actinic cheilitis and 1 with varicella. The results obtained have revealed that the preparation is particularly effective in the treatment of dermatoses induced by herpes zoster and herpes simplex virus.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002613:Cheilitis / Q000188:drug therapy; D002644:Chickenpox / Q000188:drug therapy; D002648:Child; D003877:Dermatitis, Contact / Q000188:drug therapy; D004341:Drug Evaluation; D004485:Eczema / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D009824:Ointments; D011711:Pyoderma / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D013844:Thiazoles / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D009824:Ointments; D013844:Thiazoles; C027999:5-(benzoylamino)-N-(4-chlorophenyl)-3-methyl-4-isothiazolecarboxamide